Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma-Based Genotyping in Advanced Solid Tumors: A Comprehensive Review. | Cancers (Basel) | 2021 | 34771462 | PubTator, text mining | PubMed |
| Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling. | Int J Mol Sci | 2021 | 34769401 | PubTator, text mining | PubMed |
| Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets. | Int J Mol Sci | 2021 | 34769131 | PubTator, text mining | PubMed |
| Mouse Models of CMML. | Int J Mol Sci | 2021 | 34768940 | PubTator, text mining | PubMed |
| Primary Amenorrhea Due to Anatomical Abnormalities of the Reproductive Tract: Molecular Insight. | Int J Mol Sci | 2021 | 34768925 | PubTator, text mining | PubMed |
| Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma. | Int J Mol Sci | 2021 | 34768783 | PubTator, text mining | PubMed |
| Dynamics of Transcription Factors in Three Early Phases of Osteogenic, Adipogenic, and Chondrogenic Differentiation Determining the Fate of Bone Marrow Mesenchymal Stem Cells in Rats. | Front Cell Dev Biol | 2021 | 34765608 | PubTator, text mining | PubMed |
| Epigenetic approaches for cervical neoplasia screening (Review). | Exp Ther Med | 2021 | 34765022 | PubTator, text mining | PubMed |
| Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis. | Front Oncol | 2021 | 34760702 | PubTator, text mining | PubMed |
| The telomere complex and the origin of the cancer stem cell. | Biomark Res | 2021 | 34736527 | PubTator, text mining | PubMed |
| Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemia. | Nat Cancer | 2021 | 34734190 | PubTator, text mining | PubMed |
| Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report. | Braz J Med Biol Res | 2021 | 34730684 | PubTator, text mining | PubMed |
| Identifying a molecular profile to predict the risk of recurrence in high-intermediate risk endometrial cancer. | Cancer Med | 2021 | 34729947 | PubTator, text mining | PubMed |
| Bayesian variable selection for high-dimensional data with an ordinal response: identifying genes associated with prognostic risk group in acute myeloid leukemia. | BMC Bioinformatics | 2021 | 34727888 | PubTator, text mining | PubMed |
| MicroRNA-139-5p Alleviates High Glucose-Triggered Human Retinal Pigment Epithelial Cell Injury by Targeting LIM-Only Factor 4. | Mediators Inflamm | 2021 | 34725544 | PubTator, text mining | PubMed |
| Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention. | Front Oncol | 2021 | 34722321 | PubTator, text mining | PubMed |
| miR-381-3p attenuates doxorubicin resistance in human anaplastic thyroid carcinoma via targeting homeobox A9. | Int J Exp Pathol | 2021 | 34719830 | PubTator, text mining | PubMed |
| Infant leukaemia - faithful models, cell of origin and the niche. | Dis Model Mech | 2021 | 34713888 | PubTator, text mining | PubMed |
| Circular RNA FOXO3 accelerates glycolysis and improves cisplatin sensitivity in lung cancer cells via the miR-543/Foxo3 axis. | Oncol Lett | 2021 | 34712363 | PubTator, text mining | PubMed |
| MEIS1 in Hematopoiesis and Cancer. How MEIS1-PBX Interaction Can Be Used in Therapy. | J Dev Biol | 2021 | 34698191 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=56